Literature DB >> 23822805

K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

Amy L Patton1, Krishna C Chimalakonda, Cindy L Moran, Keith R McCain, Anna Radominska-Pandya, Laura P James, Charles Kokes, Jeffery H Moran.   

Abstract

Limited forensic and clinical experience and the lack of confirmatory testing strategies for synthetic cannabinoids (SC) prevent adequate characterization of SC toxicity and the potential impact on public health. A statewide surveillance system identified a fatality involving a 23-year-old man found with a large stab wound to the neck following use of a SC product suspected of containing AM2201. Analytical testing for common SCs, SC metabolites, routine drugs of abuse, and over-the-counter medications was performed on heart blood obtained at autopsy. Additionally, assays were performed on the SC raw material and drug paraphernalia found on the decedent. High concentrations of AM2201 were detected in all samples. AM2201 metabolites were detected in postmortem blood. Other than a trace amount of JWH-073 found in smoke residue, no other substances were detected. Psychiatric complications including self-induced, lethal trauma can occur after the use of SC products.
© 2013 American Academy of Forensic Sciences.

Entities:  

Keywords:  AM2201; K2 toxicity; designer drugs; drug metabolism; forensic science; forensic toxicology; human fatality; spice toxicity; synthetic cannabinoid

Mesh:

Substances:

Year:  2013        PMID: 23822805      PMCID: PMC4319529          DOI: 10.1111/1556-4029.12216

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  21 in total

1.  Smart resource allocation needed to study 'legal highs'.

Authors:  Jeffery H Moran
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

2.  Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework.

Authors:  Kevin G Shanks; Tim Dahn; Andrea R Terrell
Journal:  J Anal Toxicol       Date:  2012-04       Impact factor: 3.367

3.  Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals.

Authors:  Susanna Every-Palmer
Journal:  Addiction       Date:  2010-10       Impact factor: 6.526

4.  Identification of a cannabinoid analog as a new type of designer drug in a herbal product.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Nobuo Kawahara; Yuji Haishima; Yukihiro Goda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2009-04       Impact factor: 1.645

5.  Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

Authors:  Krishna C Chimalakonda; Cindy L Moran; Paul D Kennedy; Gregory W Endres; Adam Uzieblo; Paul J Dobrowolski; E Kim Fifer; Jeff Lapoint; Lewis S Nelson; Robert S Hoffman; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-07-27       Impact factor: 6.986

6.  "Spice" girls: synthetic cannabinoid intoxication.

Authors:  Aaron B Schneir; Jennifer Cullen; Binh T Ly
Journal:  J Emerg Med       Date:  2010-12-17       Impact factor: 1.484

7.  Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

Authors:  Sebastian Dresen; Nerea Ferreirós; Michael Pütz; Folker Westphal; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2010-10       Impact factor: 1.982

8.  Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

Authors:  Cindy L Moran; Vi-Huyen Le; Krishna C Chimalakonda; Amy L Smedley; Felisia D Lackey; Suzanne N Owen; Paul D Kennedy; Gregory W Endres; Fred L Ciske; James B Kramer; Andrei M Kornilov; L D Bratton; Paul J Dobrowolski; William D Wessinger; William E Fantegrossi; Paul L Prather; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-05-06       Impact factor: 6.986

9.  Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Authors:  Liana Fattore; Walter Fratta
Journal:  Front Behav Neurosci       Date:  2011-09-21       Impact factor: 3.558

10.  Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".

Authors:  Ulrich S Zimmermann; Patricia R Winkelmann; Max Pilhatsch; Josef A Nees; Rainer Spanagel; Katja Schulz
Journal:  Dtsch Arztebl Int       Date:  2009-07-03       Impact factor: 5.594

View more
  19 in total

1.  High-resolution mass spectrometric determination of the synthetic cannabinoids MAM-2201, AM-2201, AM-2232, and their metabolites in postmortem plasma and urine by LC/Q-TOFMS.

Authors:  Kei Zaitsu; Hiroshi Nakayama; Mayumi Yamanaka; Kazuaki Hisatsune; Kentaro Taki; Tomomi Asano; Tooru Kamata; Munehiro Katagai; Yumi Hayashi; Maiko Kusano; Hitoshi Tsuchihashi; Akira Ishii
Journal:  Int J Legal Med       Date:  2015-09-08       Impact factor: 2.686

Review 2.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

Review 3.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

4.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

Review 5.  Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS.

Authors:  Adarsh S Gandhi; Mingshe Zhu; Shaokun Pang; Ariane Wohlfarth; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Bioanalysis       Date:  2014-06       Impact factor: 2.681

7.  Pharmacodynamic Effects, Pharmacokinetics, and Metabolism of the Synthetic Cannabinoid AM-2201 in Male Rats.

Authors:  Jeremy Carlier; Ariane Wohlfarth; Bonita D Salmeron; Karl B Scheidweiler; Marilyn A Huestis; Michael H Baumann
Journal:  J Pharmacol Exp Ther       Date:  2018-09-28       Impact factor: 4.030

Review 8.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

9.  Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Jeremy Carlier; Karl B Scheidweiler; Ariane Wohlfarth; Bonita D Salmeron; Michael H Baumann; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-06       Impact factor: 4.759

10.  High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes.

Authors:  Adarsh S Gandhi; Ariane Wohlfarth; Mingshe Zhu; Shaokun Pang; Marisol Castaneto; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-05-14       Impact factor: 3.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.